Inside Science: Why Alzheimer's Drug Trials Keep Failing

Wednesday, March 14, 2018 Drug News
Email Print This Page Comment bookmark
Font : A-A+

The causes and consequences of failed Alzheimer's research are presented from a personal angle in a new story from nonprofit journalism news service Inside Science (ISNS)

WASHINGTON, March 13, 2018 /PRNewswire-USNewswire/ -- In a new story for Inside Science News Service, Joel

Shurkin offers an intimate look at why Alzheimer's research is failing to help patients, including his own wife. Read the story for free at: https://www.insidescience.org/news/Alzheimer's-Drug-Trials-Keep-Failing/

Inside Science is an editorially-independent nonprofit journalism venture operated by the American Institute of Physics.

Researchers have long believed that Alzheimer's disease symptoms are caused by protein deposits called "amyloid plaques." But the amyloid model may be wrong, writes Shurkin, and that could explain why so many new drugs have failed in clinical trials. Shurkin's wife was a patient in a now-canceled trial, and her story offers a poignant glimpse of the human cost of such failures.

Shurkin explains the science that led to the amyloid model, as well as the creeping doubts now rising amongst Alzheimer's researchers. He goes on to describe potential new directions for future research -- research that will be too late for his wife, but perhaps life-saving for others down the road. 

ABOUT INSIDE SCIENCEInside Science is an editorially-independent nonprofit science news service run out of the American Institute of Physics and supported by a coalition of underwriters. It produces original breaking news stories, features, essays, illustrations, documentaries, animations and news videos, all of which are procurable for syndication by news organizations or available on our web site. https://www.insidescience.org

ABOUT AIPThe American Institute of Physics is an organization of physical science societies, representing scientists, engineers, educators, and students. AIP delivers valuable services and expertise in education and student programs, science communications, government relations, career services, statistical research in physics employment and education, industrial outreach and the history of physics and allied fields. AIP publishes Physics Today, the most closely followed magazine of the physical sciences community. http://www.aip.org

For More Information:AIP Media Servicesmedia@aip.org301-209-3090

Cision View original content:http://www.prnewswire.com/news-releases/inside-science-why-alzheimers-drug-trials-keep-failing-300613491.html

SOURCE Inside Science



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store